PUBLISHER: The Business Research Company | PRODUCT CODE: 1942804
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942804
Embolic protection devices are specialized medical tools designed to capture and remove embolic debris that might be dislodged during cardiovascular procedures, such as transcatheter aortic valve replacement (TAVR) or carotid artery stenting. These devices are essential for preventing strokes and other complications by trapping debris before it reaches critical organs.
The main types of embolic protection devices include distal filter devices, distal occlusion devices, and proximal occlusion devices. Distal filter devices are specifically designed to catch and remove embolic particles that could travel downstream during procedures, thereby preventing blockages in smaller blood vessels. These devices are used in the treatment of cardiovascular disease, neurovascular disease, and peripheral disease. They are employed by hospitals, ambulatory surgical centers, and other medical facilities.
Tariffs are impacting the embolic protection devices market by increasing costs for imported nitinol components, precision filters, and catheter-based delivery systems. These effects are most visible across distal filter and occlusion device segments, particularly in hospitals and ambulatory surgical centers in regions dependent on global medical device supply chains such as Asia-Pacific and Europe. Higher tariffs have modestly increased procedural device costs and inventory expenses. At the same time, tariffs are encouraging localized manufacturing, alternative material sourcing, and regional supplier development, supporting long-term supply chain resilience.
The embolic protection devices market research report is one of a series of new reports from The Business Research Company that provides embolic protection devices market statistics, including embolic protection devices industry global market size, regional shares, competitors with a embolic protection devices market share, detailed embolic protection devices market segments, market trends and opportunities, and any further data you may need to thrive in the embolic protection devices industry. This embolic protection devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The embolic protection devices market size has grown strongly in recent years. It will grow from $1.23 billion in 2025 to $1.33 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to growth in transcatheter cardiovascular procedures, increasing incidence of stroke during interventional procedures, expansion of catheter-based treatment adoption, rising awareness of embolic risks in vascular interventions, technological improvements in filter and occlusion designs.
The embolic protection devices market size is expected to see strong growth in the next few years. It will grow to $1.84 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing volumes of TAVR and carotid artery stenting procedures, growing aging population with cardiovascular disease, rising demand for safer minimally invasive interventions, expansion of neurovascular intervention procedures, increasing clinical focus on procedural risk reduction. Major trends in the forecast period include rising adoption of embolic protection in structural heart procedures, growing use of embolic protection in carotid and neurovascular interventions, increasing preference for distal filter-based protection devices, expansion of embolic protection in minimally invasive procedures, rising focus on stroke prevention during cardiovascular interventions.
The rising incidence of cardiovascular disorders is expected to drive the growth of the embolic protection devices market. Cardiovascular disorders, including conditions such as heart attacks, strokes, and hypertension, affect the heart and blood vessels, disrupting blood circulation and leading to various health issues. Urbanization often brings lifestyle changes, including reduced physical activity, increased pollution, and higher consumption of unhealthy foods. Additionally, poor dietary habits and high obesity rates contribute significantly to the rise in cardiovascular problems. Embolic protection devices are designed to capture and remove debris that could obstruct blood flow during cardiovascular procedures, minimizing the risk of complications like strokes and improving the safety and efficacy of interventions. For example, in August 2025, according to the National Center for Biotechnology Information, a US-based governmental agency, cardiovascular disease is projected to increase substantially between 2025 and 2050, with prevalence rising by 90.0%, crude mortality by 73.4%, and crude DALYs by 54.7%, resulting in an estimated 35.6 million cardiovascular deaths in 2050, up from 20.5 million in 2025. Therefore, the increasing prevalence of cardiovascular disorders is driving the growth of the embolic protection device market.
Leading companies in the embolic protection devices market are concentrating on the development of advanced technologies, such as 3-in-1 carotid stenting systems, to enhance patient outcomes by improving the efficiency and safety of procedures, minimizing complications, and providing more comprehensive protection during carotid artery interventions. The 3-in-1 carotid stenting system is a medical device that combines embolic protection, stenting, and balloon angioplasty into a single solution, designed to increase the safety and effectiveness of carotid artery stenting procedures. For example, in October 2024, Contego Medical, a U.S.-based company specializing in embolic protection devices for cardiovascular and peripheral vascular procedures, received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for its Neuroguard IEP System. This advanced 3-in-1 carotid stenting system integrates a high-performance stent, dilation balloon, and embolic filter, simplifying the procedure and improving safety by effectively capturing embolic particles that other traditional protection systems might miss.
In September 2024, Boston Scientific Corporation, a US-based medical device company, acquired Silk Road Medical Inc. for an undisclosed amount. Through this acquisition, Boston Scientific aims to expand its peripheral vascular portfolio, enhance minimally invasive treatment solutions for carotid artery disease, and improve patient outcomes through innovative vascular technologies. Silk Road Medical Inc. is a US-based medical device company specializing in embolic protection devices.
Major companies operating in the embolic protection devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc., Cook Medical LLC, Terumo Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG, Silk Road Medical Inc., InspireMD Inc., Contego Medical LLC, Transverse Medical Inc., Emboline Inc., AngioSlide Ltd., Veryan Medical Ltd., Allium Medical Solutions Ltd., Cardiatis SA, Filterlex Medical Ltd., Emboshield Medical Ltd., TriGuard Medical Ltd.
North America was the largest region in the embolic protection devices market in 2025. The regions covered in the embolic protection devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the embolic protection devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The embolic protection devices market consists of sales of filter devices, diaphragm protection devices, and guidewire-based devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Embolic Protection Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses embolic protection devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for embolic protection devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The embolic protection devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.